The federal hemp ban will create a pet-safety problem – and no one is talking about it

Hemp-derived CBD products for pets are popular, and are at risk of going away thanks to the federal hemp ban.
Published: November 20, 2026
hemp cbd for pets, The federal hemp ban will create a pet-safety problem – and no one is talking about it

Lee Asher (courtesy photo)

(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, mjplease submit your request here.)

For most of the past decade, buying cannabis products intended to enhance the life and longevity of pets was one of the simplest transactions in American retail: order a package online, and have it show up at your door. Just like Amazon, just like anything else.

But that’s going away. As state and federal governments tighten restrictions on intoxicating hemp-derived cannabinoid products, formulations used by pet owners for wellness purposes are also affected.

Unless Congress and President Donald Trump act, a federal hemp redefinition will take effect on December 11, 2026. In the meantime, an increasing number of states have imposed new rules on what hemp compounds can be sold, shipped or possessed within their borders.

new framework ctas (2)

 

Pet CBD products use many of the same hemp-derived ingredients and supply chains. But not every CBD product will be affected in the same way.

Does the federal hemp ban affect CBD products for pets?

CBD isolate is not itself automatically prohibited. At issue is the revised federal definition of hemp. The standard is no longer limited to Delta-9 THC.

Final hemp-derived cannabinoid products containing more than 0.4 milligrams of combined total THC and certain other THC-like cannabinoids per container are now “marijuana.”

Subscribe to the MJBiz Factbook  

Exclusive industry data and analysis to help you make informed business decisions and avoid costly missteps. All the facts, none of the hype. 

What you will get: 

  • Monthly and quarterly updates, with new data & insights
  • Financial forecasts + capital investment trends
  • State-by-state guide to regulations, taxes & market opportunities
  • Annual survey of cannabis businesses
  • Consumer insights
  • And more!

The issue is more complicated for full-spectrum products, which retain a broader range of compounds from the hemp plant and may contain trace amounts of THC.

Some pet owners choose full-spectrum products because they want a broader cannabinoid profile.

Moving to a CBD isolate-based formula may seem a practical option. But the formulations are not identical, and one should not assume that a replacement will work the same way for every animal.

Will CBD isolate products work on pets the same as full-spectrum?

The current 2018 Farm Bill framework does allow sellers to offer highly intoxicating products that are technically within the rules. The new law is intended to address that problem, but its broad approach may also affect legitimate products and the consumers who use them.

The concern is particularly serious for pet parents who have been using full-spectrum CBD as part of a veterinarian-guided approach to managing seizures.

Over-the-counter (or online) CBD products are not a substitute for veterinary diagnosis or prescribed treatment. No brand should promise that an alternative formula will control seizures.

But the possibility that a pet owner may lose access to a product they believe has helped their animal deserves more attention in this policy debate.

A pet owner may be giving a dog a product that no longer meets the rules in their state.

That’s a serious safety problem that needs addressing.

What should pet owners who use CBD do after the federal hemp ban?

In our Pet Wellness Consumer Trends Report 2026, 29% of respondents said they had given their pet a CBD supplement in the past year. More people give their pets CBD than take CBD themselves.

And this isn’t what you’ve heard about over the past year, as low-dose hemp-THC beverages, THCA flower and questions of equity and access dominate the debate. Pet owners aren’t talked about at all.

My business partner, D.J. Gugenheim, puts it this way: nobody is writing the headline about the 70-year-old in Baton Rouge who has to find a different option to extend the life and wellness of her arthritic Labrador after the product she has been buying changes or disappears.

We believe that the work of staying compliant under changing rules and the work of taking care of the customer are the same work.

A product that cannot legally be shipped to a customer’s state is not an option for that customer. It’s a liability, for everyone.

Does the FDA allow for CBD in pet products?

Separate from but related to the new hemp definition are the longstanding U.S. Food and Drug Administration rules around supplements, product safety, what you can add and what you can say.

Notably, the FDA has not approved CBD for use in animals. A product marketed to diagnose, cure, mitigate, treat or prevent a disease in an animal can be considered a new animal drug, which generally requires FDA approval or another applicable authorization before it can be legally marketed.

Whether or not the ban goes forward, companies need to be careful about the claims they make on product labels, websites, social media, advertisements and customer materials.

A brand should not say that a CBD product treats seizures, arthritis or anxiety, or imply that it can replace veterinary care, unless it has the regulatory authorization to make that claim.

Claims should be accurate, supported by research and reviewed by counsel before slapped on a label or posted online.

Brands should explain what is in a product, provide accessible testing information and encourage pet owners to consult their veterinarians, especially when an animal has a diagnosed condition or takes medication.

And this FDA compliance gap is a problem that needs solving no matter what happens with the federal hemp ban.

How to ensure pet CBD products remain available

No single company can solve this on their own. But over the next year, I believe both the pet-focused cannabinoid industry and state and federal regulators should make these three points their priorities.

  • Give companies and consumers clearer federal guidance. The new total-THC standard is arriving in a market that spent years building products around a delta-9 threshold. Regulators should explain how the rules apply to different formulations and provide clear information about testing and compliance.
  • Require reliable third-party lab testing. An independently verified Certificate of Analysis should be standard. Customers should be able to see what a product contains, including its cannabinoid profile and THC levels.
  • Give consumers state-by-state transparency. Brands should build tools that obey current compliance standards so customers can see whether a product can be legally shipped to their address before they buy it, rather than learning only after an order is canceled.

In the meantime, operators can take practical steps: audit their product catalogs, state-by-state if necessary; review formulations against the new Dec. 11 standard, test current inventory of finished products as well as new formulations, and stop shipping wherever the product is no longer compliant.

The goal here is not to preserve every product that exists today. Instead, it’s to distinguish responsibly crafted, non-intoxicating products from those that created legitimate public-health concerns – all while giving pet owners clear information and a realistic path forward.

If the industry and regulators fail to make that distinction, pets and the people caring for them will pay a price for a legitimate crisis that was never really about them.

 

 

MJBizCon Logo